Cargando…
CAR-T design: Elements and their synergistic function
Chimeric antigen receptor (CAR) T cells use re-engineered cell surface receptors to specifically bind to and lyse oncogenic cells. Two clinically approved CAR-T–cell therapies have significant clinical efficacy in treating CD19-positive B cell cancers. With widespread interest to deploy this immunot...
Autores principales: | Jayaraman, Jayapriya, Mellody, Michael P., Hou, Andrew J., Desai, Ruchi P., Fung, Audrey W., Pham, An Huynh Thuy, Chen, Yvonne Y., Zhao, Weian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7393540/ https://www.ncbi.nlm.nih.gov/pubmed/32739874 http://dx.doi.org/10.1016/j.ebiom.2020.102931 |
Ejemplares similares
-
A high throughput bispecific antibody discovery pipeline
por: Segaliny, Aude I., et al.
Publicado: (2023) -
CAR-Macrophages and CAR-T Cells Synergistically Kill Tumor Cells In Vitro
por: Liu, Maoxuan, et al.
Publicado: (2022) -
Acoustic Radiation Force Impulse Imaging in Benign and Malignant Breast Lesions
por: Jayaraman, Jayapriya, et al.
Publicado: (2017) -
The development of CAR design for tumor CAR-T cell therapy
por: Xu, Dandan, et al.
Publicado: (2018) -
Incorporation of functional elements enhances the antitumor capacity of CAR T cells
por: Qin, Le, et al.
Publicado: (2017)